01:56 Wed 23 Oct 2019
Haystack Sciences CEO Eddie Watts sat down with Proactive at the BIO Investor Forum in San Francisco.
San Francisco-based, privately-held Haystack is developing methods for drug discovery to help find new cures for difficult-to-treat disorders using its indexer technology.
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
FOR OUR FULL DISCLAIMER CLICK HERE
Director Interviews
Director Interviews
Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) CEO Seth Lederman sat down with Proactive at the BIO CEO & investor Conference in New York. Lederman says the biopharma company had recently unveiled the pre-clinical results of TNX-801, its live virus horsepox vaccine that prevents...
Director Interviews
Full interview: Matinas BioPharma to begin dosing HIV patients...
Prev article
